For example, previous data suggest that the neuregulin/HER3 autocrine loop drives the growth of ovarian tumors in vivo, and HER3 was identified as a potential therapeutic target in ovarian cancer [13]. This evidence concerns the gene ERBB3 and ovarian carcinoma.